Orleans Capital Management Corp Gilead Sciences, Inc. Transaction History

Orleans Capital Management Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2018 Nov 15, 2018	SELL	$71.28 - $78.92 $860,563 - $952,801	-12,073 Closed	0 $0
Q2 2018 Aug 20, 2018	SELL	$64.88 - $75.68 $15,571 - $18,163	-240 Reduced 1.95%	12,073 $855,000
Q1 2018 May 15, 2018	BUY	$72.84 - $88.8 $28,116 - $34,276	386 Added 3.24%	12,313 $928,000
Q4 2017 Feb 09, 2018	SELL	$71.15 - $83.52 $362,153 - $425,116	-5,090 Reduced 29.91%	11,927 $854,000
Q3 2017 Nov 20, 2017	BUY	$72.11 - $85.47 $1.23 Million - $1.45 Million	17,017	17,017 $1.38 Million

1,931

991M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Orleans Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Orleans Capital Management Corp with notifications on news.